Brochure | March 23, 2021

Irvine Dry Powder Media Facility

Our Dry Powder Media manufacturing facility located in Irvine, Scotland completes a Capital Expansion Plan initiated as part of its long-term commitment to supporting customers in the growing industrial biopharmaceutical market. The purpose-built facility produces animal component free media and offers regional support to the European market along with manufacturing redundancy to its North American sister facility in Lenexa, Kansas. This document presents details of the validation strategy for the new facility and an overview of the harmonization approach to ensure comparability with the Lenexa plant. #Biopharm

access the Brochure!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online